CAR T Cells Targeting CD30 Positive Lymphomas (4SCAR30273)
Clinical trial NCT02274584 · UNKNOWN
Trial details
- NCT number
- NCT02274584
- Sponsor
- Peking University
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2016-10-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.